
|Articles|April 1, 2004
Angiogenesis plays role in ophthalmic diseases
Editor's Note: Due to the large volume of information presented at the Angiogenesis 2004 meeting, this article is an overview of many of the presentations. Ophthalmology Times will provide greater detail of many of the sessions in upcoming issues.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
2
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease
3
Strategic approaches optimize teaching and learning in the clinic
4
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
5












































.png)


